Physical Activity and Cognition Study (CTSI)

April 19, 2020 updated by: Boston University

Feasibility of Using Physical Activity Monitoring for Enhancing Cognition in Healthy Seniors

The goal of this research study is to examine whether an intervention to increase physical activity using a body-worn sensor affects cognitive (thinking) processes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The overall duration of participation in this research study is approximately 4 months. During this time, three study visits will be required. The first visit is for informed consent and screening, the second visit is for baseline fitness and cognitive testing, and the third visit is for follow-up fitness and cognitive testing after a 12-week physical activity monitoring program. Participants will be randomized to one of two study arms, a physical activity monitoring arm and a flexibility and balance arm. Both study arms involve wearing a physical activity sensor and monitoring physical activity for a duration of 12 weeks.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02118
        • Boston University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Non-smoking
  • Age between 55-85 years
  • Sedentary status (physically inactive; not participating in at least 30 minutes of moderate intensity physical activity on at least three days per week for at least three months)
  • Generally healthy men and women
  • Living in the greater Boston area
  • Available for the 4 month duration of the study
  • Native-English speaking or fluent in English (must have attended elementary school and higher in English)

Exclusion Criteria:

  • Poor vision that cannot be corrected with glasses or contact lenses
  • Presence of an acute infection
  • Diagnosis of kidney failure
  • Diagnosis of liver disease
  • Diagnosis of thyrotoxicosis/hyperthyroidism
  • Diagnosis of cancer
  • Past or present conditions that affect cognitive functioning:

    1. learning disability
    2. neurological disorders or conditions (movement disorder, history of head trauma or stroke, epilepsy, etc.)
    3. psychiatric disorders or conditions (depression, anxiety disorder, etc.)
  • Past or present conditions that are counter indicators for participation in cardio-respiratory fitness assessment and moderate-intensity physical activity:

    1. heart conditions (e.g. heart attack, arrhythmias, etc.)
    2. circulatory conditions (e.g. uncontrolled hypertension, leg claudication, high cholesterol, etc.)
    3. respiratory conditions (e.g., asthma or lung conditions, such as chronic obstructive pulmonary disease, acute bronchitis, acute common cold, lung cancer, pneumonia, etc.)
    4. current musculoskeletal impairments (e.g. fractures, hemiplegia, chronic joint pain, arthritis, osteoporosis, not able to walk comfortably without assistance, etc.)
    5. diagnosis of electrolyte disorder or abnormality
    6. presence of diabetes mellitus
  • Obesity
  • Prescription medication or other drugs that treat heart, lung, or circulatory conditions (e.g. beta blockers, bronchodilators, etc.)
  • Prescription medication or other drugs that affect chemicals in the brain (e.g. antidepressants, anxiolytics, etc.)
  • Implanted medical devices, such as a pacemaker or defibrillator
  • Unavailable for the approx. 4-month duration of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Physical activity monitoring
Participants will wear a physical activity sensor on the hip or waist with a belt. They will be instructed to increase their physical activity level to at least 150 min of moderate-intensity physical activity per week. They will be asked to follow guidelines in the "Go4Life" brochure, website, and/or videos by the National Institute on Aging. Participants will receive weekly phone calls to monitor their progress, to provide feedback, and to suggest example exercises.
Trainer-guided at-home behavioral intervention
Active Comparator: Flexibility and balance
Participants will wear a physical activity sensor on the hip or waist with a belt. They will be instructed to increase their balance and flexibility over the 12 week period of the intervention. They will be asked to follow guidelines in the "Go4Life" brochure, website, and/or videos by the National Institute on Aging. Participants will receive weekly phone calls to monitor their progress, to provide feedback, and to suggest example exercises.
Trainer-guided at-home behavioral intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognition
Time Frame: 80-90 minutes
Change in cognitive task performance post-intervention compared to baseline
80-90 minutes
Aerobic Fitness
Time Frame: 30 minutes
Change aerobic fitness measured with treadmill test post-intervention
30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional fitness: Five Times Sit to Stand
Time Frame: 10 min
Change in performance in the Five Times Sit to Stand test post-intervention
10 min
Functional fitness: Timed Get Up and Go
Time Frame: 10 min
Change in performance in the Timed Get Up and Go test post-intervention compared to baseline
10 min
Functional fitness: Flexibility
Time Frame: 10 min
Change in performance in the Sit and Reach test post-intervention
10 min
Physical activity
Time Frame: 12 weeks
Greater overall moderate-intensity physical activity time and step count and lower sedentary time in the physical activity monitoring than the flexibility and balance group
12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait: step and stride time
Time Frame: 12 weeks
Change in step and stride time over 12 weeks
12 weeks
Gait: stride time variability
Time Frame: 12 weeks
Change in stride time variability over 12 weeks
12 weeks
Gait: gait symmetry
Time Frame: 12 weeks
Change in gait symmetry over 12 weeks
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karin Schon, Ph.D., Boston University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2017

Primary Completion (Actual)

January 17, 2020

Study Completion (Actual)

January 17, 2020

Study Registration Dates

First Submitted

May 11, 2016

First Submitted That Met QC Criteria

May 12, 2016

First Posted (Estimate)

May 16, 2016

Study Record Updates

Last Update Posted (Actual)

April 21, 2020

Last Update Submitted That Met QC Criteria

April 19, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Physical Activity

3
Subscribe